The Patent Finder
MM

Montefiore Medical Center

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

21 patents currently held

13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Sep 2027. from the record

Of the 13 now held by other companies, 8 name Albert Einstein College of Medicine as their current owner, and 5 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
5
Ending by 2030
Sep 2027
Next term end
15
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Delivery of Therapeutic Agents by a Collagen Binding Protein US 9,579,273
Cited by 13 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Ends Dec 2032 · High confidence
Also notable
Cultures and protocols for diagnosis of toxigenic clostridium difficile US 8,765,399
The largest patent family in this portfolio, 10 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2032.
Ends Feb 2032 · High confidence
Also notable
Wheelchair Attachments US 7,766,342
Renewed at every maintenance window since the 2010 grant; no more fees are due before its term ends in 2027.
Ends Sep 2027 · High confidence

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 65 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2036.
Ends Sep 2036 · High confidence
Also notable
Cited by 19 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2037.
Ends Sep 2037 · High confidence
Also notable
Cited by 34 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Ends Jan 2033 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 22, 2027
    The maintenance fee for Transfemoral Transcaval Liver Access and Devices (US 10,448,931) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
  • 1 fee due Oct 19, 2027
    The maintenance fee for Preparative Regimen for Engraftment, Growth and Differentiation of Non-Hematopoeitic Cells in Vivo After Transplantation (US 9,314,486) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 7,766,342Wheelchair Attachments
In force
 · High confidence
In forceHigh confidence
US 9,314,486Preparative Regimen for Engraftment, Growth and Differentiation of Non-Hematopoeitic Cells in Vivo After Transplantation
In force
 · High confidence
In forceHigh confidence
US 7,734,477System and Method for Monitoring Patient Care
In force
 · High confidence
In forceHigh confidence
US 8,475,340Hypoxic Conditioning in Patients with Exercise Limiting Conditions
In force
 · High confidence
In forceHigh confidence
US 8,845,654Scaled Head Frame Positioner and Tabletop Adapter
In force
 · Medium confidence
In forceMedium confidence
US 8,765,399Cultures and protocols for diagnosis of toxigenic clostridium difficile
In force
 · High confidence
In forceHigh confidence
US 9,579,273Delivery of Therapeutic Agents by a Collagen Binding Protein
In force
 · High confidence
In forceHigh confidence
US 11,001,820Delivery of Therapeutic Agents by a Collagen Binding Protein
In force
 · High confidence
In forceHigh confidence
US 11,992,195Transfemoral Transcaval Liver Access and Devices
In force
 · Medium confidence
In forceMedium confidence
US 11,504,100Transfemoral Transcaval Liver Access and Devices
In force
 · High confidence
In forceHigh confidence
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
Also on record, not counted in the 21: 13 patents in force now held by others · 6 patents ended · 9 applications pending · 16 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited